Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Rotemberg, Veronica Miriam

Sloan-Kettering Inst Can Research
United States

M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection 5U24CA264369-03 Guillermo Marquez, Ph.D.
Roth, Michael E.

Public Health Institute
United States

Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant 3UG1CA189955-11S2 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rowland, Kendrith Martin

Carle Foundation
United States

Carle Cancer Center NCI Community Oncology Research Program (NCORP) 5UG1CA189861-11 Vanessa A. White, M.P.H.
Russell, John A

University Of Wisconsin-Madison
United States

Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment 5R37CA225608-07 Cecilia Lee, Dr.P.H., RN
Saenger, Yvonne Margaret

Albert Einstein College Of Medicine
United States

Applying pathomics to establish a biosignature for aggressive skin melanoma 5R01CA260375-04 Guillermo Marquez, Ph.D.
Salami, Simpa Samuel

University Of Michigan At Ann Arbor
United States

Defining the Biological Arc of Grade Group 1 Prostate Cancer 5R37CA283857-02 Guillermo Marquez, Ph.D.
Salkowski, Lonie

University Of Wisconsin-Madison
United States

Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection 5R37CA262110-04 Guillermo Marquez, Ph.D.
Salman, Emad

Florida Assn Of Pediatric Tumor Prog
United States

The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program. 5UG1CA189973-11 Vanessa A. White, M.P.H.
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-04 Rachel Altshuler, Ph.D.
Salvemini, Daniela

Saint Louis University
United States

A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity 5R01CA230512-05 Rachel Altshuler, Ph.D.